January 7, 2021
Meet the newest members of the MATTER startup community
The newest MATTER startups are improving the quality of life for those with pulmonary fibrosis, providing tools to create accessible online mental health clinics and solving for hydrocephalus. Take a minute to meet them and see the heroic change in healthcare happening today.
OxyGEN — Baltimore, Maryland
OxyGEN, a medtech venture out of Johns Hopkins University in Baltimore, was selected as the first place winner of the 2020 Pulmonary Fibrosis Innovation Challenge and received $50,000 to advance their solution and a one year membership to MATTER. OxyGEN’s solution is a high-flow portable oxygen concentrator that tracks, monitors and automatically adjusts the oxygen level for each patient, improving mobility and quality of life. When combined with high-flow air, lower levels of oxygen can be effective in treating hypoxemia, providing longer lasting and more effective portable treatment.
OPTT — Toronto, Ontario
OPTT is a virtual behavioral health platform powered by clinically validated interactive, digital care plans and AI algorithms that allow evidence based decision making based on personalized data and behavioral phenotyping. OPTT is designed to improve the efficiency of behavioral care delivery while supporting patients with everyday health challenges and enabling asynchronous patient provider communications. Their solution enables caregivers to provide clinically sound, efficient, stigma-free, and fully customizable interactive therapy to their patients. Each of OPTT’s therapy modules or commercially available content has undergone extensive research and testing and has been validated over five clinical trials.
Rhaeos — Chicago, Illinois
Rhaeos was founded to address the unmet need in the care of patients with hydrocephalus — a life threatening condition caused by an abnormal accumulation of cerebrospinal fluid in the brain that affects more than one million Americans today. Rhaeos has developed a wireless, noninvasive thermal sensor to monitor ventricular shunt function called FlowSense. Similar in size to a bandage, FlowSense is composed of soft silicone with no hard edges and is programmed to have data wirelessly transmitted to a mobile app. With FlowSense, monitoring of shunt function can occur in clinics, in-patient settings and emergency departments reducing unnecessary imaging, hospital length of stay and readmission costs.
Interested in becoming part of the MATTER startup community? Learn more about our startup memberships here.